Industry
NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer
The University of Texas MD Anderson Cancer Center and NanoString Technologies will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology and to extend targeted therapeutics programs. More...13 Apr 2015
Microbiologics and Microbix Partner on Viral Controls for Diagnostics
Microbiologics has entered into an agreement to source inactivated viruses from Microbix Biosystems to be incorporated into a line of full process controls under Microbiologics’ Helix Elite Molecular Standards brand as well as instrument-specific quality control sets. More...12 Apr 2015
Philips Collaborates with Janssen on Handheld Test for Neuropsychiatric Disorders
Royal Philips has entered into a multiyear development agreement with Janssen Pharmaceutica NV to develop a novel point-of-care blood test to improve the care of patients with neuropsychiatric disorders. More...05 Apr 2015
Latin America’s IVD Sector Exceeds USD 2 Billion, Brazil leads
The Latin American in vitro diagnostics sector was estimated at USD 2.4 billion in 2014. Population growth, government insurance, newly insured patients, and updated healthcare facilities have driven growth in the region and will continue to propel demand, according to Kalorama Information. More...29 Mar 2015
“Softer” Mass Spec Techniques Gain Advantage in Biomarker Discovery
Two mass spectrometry technologies, MALDI and DESI, are increasing in applications as their effectiveness is established, according to Kalorama Information in its report “Proteomics Markets for Research and IVD Applications - Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies.” More...29 Mar 2015
Sequencing-Based Testing Sector Already Highly Competitive
As next-generation sequencing reaches the clinical laboratory, a new analysis by Kalorama Information finds that small reference laboratories as well as over 50 companies now offer sequencing-based testing through their own CLIA-certified laboratories, some of which offer a wide range of tests. More...22 Mar 2015
Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
In Other News
US Government Funding Initiative Includes Spotlight on Tissue Diagnostics
Lab-on-Paper Developed for Rapid Inexpensive Medical Diagnostics
Partnership Expands to Advance Novel Dual-Detection of Two Neglected Tropical Diseases
Healthcare Revolution Predicted with Rise of Genomic Testing for Personalized Medicine
Blood-Based Molecular Test Improves Early Detection of Colorectal Cancer
Social Network for Diagnostics Launched
Artel Expands Portfolio with STRATEC Partnership for Automation Technology
After First Approval of a Rapid Molecular Test, Expect More
Collaboration Agreement Targets Tumor-Related Genes
Emerging Products Provide Opportunity in Prenatal Diagnostics
Premarket Approval Sought for CDx Test to Benefit Lung Cancer Patients
Report Predicts Double-Digit Growth for Protein Microarrays
Aperiomics Presents Innovative Diagnostics Technology
WEF Selects Transasia Bio-Medicals for Global Growth Company Award
Testing On Tissues and Cells Sector Reaches USD 7.5 Billion
Bacterial Infection Assay Receives First Simultaneous FDA Clearance and CLIA Waiver
Strong Growth Forecasted for Women's Health Diagnostics
Merger Expected to Accelerate Development of Personalized Medicine Solutions
Diagnostics Rapidly Gain Ground in Infectious Diseases Sector
Robot-Assisted PCR Among Innovations Driving qPCR Sector
Roche Acquires High-Precision Dissection Technology from AvanSci Bio
Ferring and Roche Collaborate on Personalized Infertility Treatment
Roche Enters Additional Sectors with Acquisition of Ariosa
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.